Live feed17:21:04·45dINSIDERFilingEVP, Global Head of R&D & CMO Iannone Robert covered exercise/tax liability with 6,209 units of Ordinary Shares, decreasing direct ownership by 7% to 88,871 units (SEC Form 4)JAZZ· Jazz Pharmaceuticals plcHealth CareOriginal source